Loading…

P1.12-03 Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose

Saved in:

Bibliographic Details
Published in:	Journal of thoracic oncology 2019-10, Vol.14 (10), p.S535-S535
Main Authors:	Trigo Perez, J.M., Subbiah, V., Besse, B., Moreno, V., López, R., Sala, M.a., Ponce, S., Fernendez, C., Nieto, A., Kahatt, C., Zeaiter, A., Zaman, K., Boni, V., Arrondeau, J., Martinez, M., Delord, J., Awada, A., Kristeleit, R., Longo, F., Sarantopoulos, J., Rubio, M., Anton, A., Wannesson, L., Valdivia, J., Shappiro, G., Villalobos, V., Santoro, A., D'Arcangelo, M., Aparicio, L., Paz-Ares, L.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!